lonafarnib has been researched along with rm-493 in 1 studies
| Studies (lonafarnib) | Trials (lonafarnib) | Recent Studies (post-2010) (lonafarnib) | Studies (rm-493) | Trials (rm-493) | Recent Studies (post-2010) (rm-493) |
|---|---|---|---|---|---|
| 224 | 34 | 90 | 39 | 8 | 38 |
| Protein | Taxonomy | lonafarnib (IC50) | rm-493 (IC50) |
|---|---|---|---|
| Melanocortin receptor 5 | Homo sapiens (human) | 1.8838 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aschenbrenner, DS | 1 |
1 other study(ies) available for lonafarnib and rm-493
| Article | Year |
|---|---|
New Drugs for Rare Disorders.
Topics: alpha-MSH; Anti-Obesity Agents; Humans; Piperidines; Progeria; Pyridines; Rare Diseases | 2021 |